Cheryls Smith News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research and development is critical to the pharmaceutical industry. If drug prices increase, firms have more revenue and more incentive to invest in R&D. Allowing the federal government toset drug prices for Medicare Part D would reduce pharmaceuticalresources for medical innovations. The primary medical conditionaffecting a rising number of people aged 65 and over described hereis Alzheimer's disease. ....

United States , New York , Frank Lichtenberg , Cheryls Smith , America Ph , Columbia University Graduate School Of Business , Human Service Centers For Medicare Medicaid Services , Department Of Defense , Health Resources , Health Policy , National Science Foundation , Veterans Administration , Department Of Health , Department Of Defense Military Treatment Facility , Alzheimer Association , Government Accountability Office , Congressional Budget Office , Strategic Plan Development , Us Senate , Heritage Foundation , Office Of Drug Pricing , Human Services , Members Of Congress , Public Health Service , Brigham Young University , Services Administration ,